A Peek at Champions Oncology's Future Earnings
A Peek at Champions Oncology's Future Earnings
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.Champions Oncology (NASDAQ:CSBR) is gearing up to announce its quarterly earnings on Wednesday, 2024-12-11. Here's a quick overview of what investors should know before the release.
Champions Oncology (納斯達克:CSBR) 正在準備於2024-12-11週三公佈其季度業績。在發佈之前，這裏有投資者應了解的快速概述。
Analysts are estimating that Champions Oncology will report an earnings per share (EPS) of $0.01.
分析師估計，Champions Oncology 將報告每股收益（EPS）爲0.01美元。
Anticipation surrounds Champions Oncology's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
市場對Champions Oncology的公告充滿期待，投資者希望聽到超出預期以及對下個季度的積極指引。
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
新投資者應理解，儘管盈利表現重要，但市場反應往往受指引驅動。
Historical Earnings Performance
歷史業績表現
Last quarter the company beat EPS by $0.14, which was followed by a 9.58% increase in the share price the next day.
上個季度，該公司超出每股收益0.14美元，次日股價上漲了9.58%。
Here's a look at Champions Oncology's past performance and the resulting price change:
以下是Champions Oncology的歷史表現及隨之而來的價格變化：
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.03 | -0.16 | -0.15 | -0.17 |
| EPS Actual | 0.11 | 0.01 | -0.16 | -0.15 |
| Price Change % | 10.0% | 3.0% | -3.0% | 5.0% |
| 季度 | 2025年第一季度 | 2024年第四季度 | 2024年第三季度 | 2024年第二季度 |
|---|---|---|---|---|
| 每股收益預估值 | -0.03 | -0.16 | -0.15 | -0.17 |
| 每股收益實際值 | 0.11 | 0.01 | -0.16 | -0.15 |
| 價格變動百分比 | 10.0% | 3.0% | -3.0% | 5.0% |
Champions Oncology Share Price Analysis
Champions Oncology 股價分析
Shares of Champions Oncology were trading at $4.88 as of December 03. Over the last 52-week period, shares are up 0.41%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
截至12月3日，Champions Oncology的股價爲4.88美元。在過去的52周內，股價上漲了0.41%。鑑於這些收益普遍積極，長期股東在此次業績發佈前可能看好。
To track all earnings releases for Champions Oncology visit their earnings calendar on our site.
要查看Champions Oncology的所有業績發佈，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審核。